Supplies and medicine – Medic Buzz Sat, 19 Nov 2022 19:34:21 +0000 en-US hourly 1 Supplies and medicine – Medic Buzz 32 32 Gladys Wanga recovers stolen medical supplies hidden in her home during the crackdown Sat, 19 Nov 2022 15:39:55 +0000
  • Gladys Wanga managed to recover stolen medical supplies hidden in a residential house during a crackdown
  • The operation was carried out by his office, in conjunction with members of state and regional security agencies
  • A group of suspected robbers broke into a county police station before seizing officers’ firearms

Exactly two months after taking office, Hima Bay Governor Gladys Wanga took the lead.

Some of the stolen medical supplies recovered. Photo: Gladys Wanga.
Source: Twitter

On Saturday, November 19, the county chief managed to recover stolen medical supplies hidden in an apartment house during a crackdown.

“This morning, my office, together with members of public and security agencies, effectively stopped the theft and recovered medical supplies destined for our hospitals,” Wanga said.

Gladys Wanga mobilizes to fight against insecurity in Homa Bay

Speaking to her official Twitter account, Wanga, elected on an Orange Democratic Movement (ODM) ticket, said her office would do whatever it takes to strengthen the Security of all county supplies.

Read also

Climate activists pour paint on Charles Ray sculpture in Paris

“The Rodi incident is regrettable and legal action is being taken against all those responsible. Hawa wataona siku mrefu. (These will see a long day),” she added.

The situation of insecurity in Homa Bay is bad because a group of suspected thieves broke in at a county police station before seizing the officers’ firearms.

According to a report filed at Mbita Police Station under number OB 17/04/11/2022, the robbers raided Kipasi patrol base on the evening of Wednesday November 16.

Runway insecurity in Homa Bay County

Police say the suspects entered after cutting the rear window of the main building that houses the station’s armory.

Inside the armory they cut the steel gun box and grabbed the guns and several turns in it.

Read also

Homa Bay: 3 cops arrested in connection with the theft of 5 firearms at the Kipasi police station

Following their preliminary investigations, the police established that the suspects had stolen the following rifle; G3 (s/n A3 6699056), G3 (s/n 6593403), G3 FMP (s/n 402994) and AK-47 (s/n 4913650).

Some stolen items

Also stolen were 80 7.62mm rounds and 30 special 7.62mm rounds.

After processing the scene by detectives from the Criminal Investigations Department (DCI), three police officers were arrested in Homa Bay for the theft of firearms and cartridges.

Confirming the arrest of the trio, Homa Bay County Commissioner Moses Lilan said detectives are still pursuing the remaining culprits.

“It was criminal intent and I want the perpetrators to know that we will definitely get hold of them and deal with them,” Lilan said.

He said a specialist team had been formed to handle the investigations.

PAY ATTENTION: Click on “See First” under the “Following” tab to see TUKO news on your newsfeed


Ionis Presents Positive Phase 2 Data from Donidalorsen Open-Label Extension Study at the 2022 ACAAI Annual Meeting Sun, 13 Nov 2022 18:01:00 +0000

Interim Results Show Sustained Reduction in Hereditary Angioedema Attacks and No New Safety Signals in Patients Treated for One Year

CARLSBAD, Calif., November 13, 2022 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported positive results from a Phase 2 open label extension (OLE) study evaluating the safety and efficacy of its antisense drug trial, donidalorsen, in patients with hereditary angioedema (HAE), a rare and devastating inflammatory disease. Interim data after all patients completed 1 year of treatment in the study showed a sustained reduction in HAE attacks and no new safety signals after donidalorsen treatment. Treatment with donidalorsen resulted in an overall sustained mean reduction in HAE attack rates of 95% from baseline. For patients treated with donidalorsen, 99.6% of study days passed without an HAE attack.

The data was presented at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting in Louisville, Ky. Additional details can be found on the ACAAI website.

“Today’s data further enhances the profile of donidalorsen and its potential to provide significant long-lasting protection against stroke for people living with hereditary angioedema,” said Richard S. Geary, Ph.D., Executive Vice President and Chief Development Officer at Ionis. “The positive OLE Phase 2 results are encouraging as we continue to evaluate donidalorsen, a potentially best-in-class drug, in the ongoing OASIS Phase 3 program.

Patients who completed the Phase 2 study were eligible for enrollment in the OLE study. There were 20 patients with HAE type 1 or type 2 in the phase 2 study, and 17 (85%) entered OLE. After a 13-week fixed-dose period in which participants received subcutaneous donidalorsen 80 mg every four weeks, eight patients were switched to subcutaneous donidalorsen 80 mg every eight weeks. Patients who remained on donidalorsen 80 mg every 4 weeks had an average reduction in attack rate of 95.3% and 98.3%, from week 1 (after the first dose) and week 5 (after the second dose), respectively. Patients receiving donidalorsen 80 mg every eight weeks had a mean attack rate reduction of 75.6% from baseline and the mean monthly attack rate was 0.28. Five of these patients remained seizure-free over the one-year duration of this analysis, and three patients returned to 80 mg every four weeks.

No serious adverse events were reported in the OLE study and no treatment-related adverse events (TEAEs) led to study discontinuation. There were no clinically relevant abnormalities in laboratory measurements.

About Hereditary Angioedema (HAE)

HAE is a rare and life-threatening genetic disease characterized by rapid and painful attacks of inflammation of the hands, feet, limbs, face, abdomen, larynx and trachea. HAE affects approximately 20,000 patients in the United States and Europe and can be fatal if swelling occurs in the larynx. In patients with frequent or severe attacks, doctors can use prophylactic treatment approaches to prevent and reduce the severity of HAE attacks.

About Donidorsen

Donidalorsen is an investigational antisense drug that uses Ionis’ advanced technologies LIghent-VSconjugate Antisense (LICA) and is designed to reduce the production of prekallikrein, or PKK, to treat patients with HAE. PKK plays an important role in the activation of inflammatory mediators associated with acute attacks of HAE. HAE is a rare genetic disease characterized by rapid and painful attacks of inflammation of the hands, feet, limbs, face, abdomen, larynx and trachea. HAE can be fatal if swelling occurs in the larynx. In patients with frequent or severe attacks, doctors can use prophylactic treatment approaches to prevent and reduce the severity of HAE attacks.

About Ionis Pharmaceuticals, Inc.

For more than 30 years, Ionis has been the leader in RNA-targeted therapy, opening new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed drugs and a leading late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision to become a leading, fully integrated biotechnology company.

To learn more about Ionis, visit and follow us on Twitter @ionispharma.

Ionis Forward-Looking Statements

This press release contains forward-looking statements regarding Ionis’ business and the therapeutic and commercial potential of Ionis’ technologies, donidalorsen and other products in development. Any statement describing Ionis’ objectives, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement. These statements are subject to certain risks and uncertainties, including those related to the impact that COVID-19 may have on our business, and including, but not limited to, those related to our commercial products and pharmaceuticals. our pipeline, and in particular those inherent in the process of discovering, developing and commercializing safe and effective drugs for human therapeutic use, and in the effort to build a business around these drugs. Ionis’ forward-looking statements also involve assumptions which, if they never materialize or prove to be incorrect, could cause its results to differ materially from those expressed or implied by such forward-looking statements.

Although Ionis’ forward-looking statements reflect the good faith judgment of its management, such statements are based solely on facts and factors currently known to Ionis. Accordingly, you are cautioned not to rely on these forward-looking statements. These and other risks relating to Ionis’ programs are further described in Ionis’ Annual Report on Form 10-K for the fiscal year ended. December 31, 2021, and the most recent quarterly filing of Form 10-Q, which is filed with the Securities and Exchange Commission. Copies of these and other documents are available from the Company.

In this press release, unless the context otherwise requires, “Ionis”, “Company”, “we”, “us” and “our” refer to Ionis Pharmaceuticals and its subsidiaries.

Ionis Pharmaceuticals® is a trademark of Ionis Pharmaceuticals, Inc.

SOURCEIonis Pharmaceuticals, Inc.

SC asks the Center to finalize the SOP on medical oxygen supply in 8 weeks | Latest India News Fri, 11 Nov 2022 03:24:30 +0000

The Supreme Court gave the Center eight weeks on Thursday to finalize guidelines on the supply of medical oxygen equipment and devices as it considers a public interest litigation (PIL) highlighting the tragic deaths of 60 children in a hospital in Gorakhpur in Uttar Pradesh, allegedly due to lack of oxygen supply.

A bench headed by Chief Justice of India (CJI) Dhananjaya Y Chandrachud said: “The Union Counsel of India says that the National Oxygen and SOP guidelines for optimal use of Medical oxygen equipment and devices are currently under review by the Department of Health and Family Welfare.

The Center informed the Court that eight more weeks will be needed to finalize everything.

Read also : Supreme Court arrests Center for delay in filing affidavit on Ram Setu

The bench, also comprising Justices Hima Kohli and JB Pardiwala, said: “In this light, we grant time, as requested, to file a counter affidavit before this Court after the directions have been duly made placing the directions and the relevant check-in policy.”

The tribunal posted the case in the third week of January.

The order came on a PIL filed by a certain Naresh Dixit.

The petition was filed in 2017 following the Gorakhpur tragedy asking for a blanket order to put in place a uniform policy on medical oxygen supply in hospitals without interruption.

He also called for an investigation into the slippages of the Gorakhpur tragedy that occurred at Baba Raghav Das Medical College.

60 children lost their lives over a period of one week, including 23 infants.

After the incident, it was alleged that the liquid oxygen supplier took this extreme measure after sending several warning letters to the public hospital to pay its accrued dues of 68 million.

Initially, the bench was not inclined to keep the matter in abeyance. He felt that the matter would be best handled by the Allahabad High Court.

Barrister Sarvesh Bisaria, who argued the PIL with Barrister Prakash Chand Sharma, urged the Court to take a holistic view as there was no uniform policy on oxygen supply in public hospitals .

The bench remarked: ‘Can we tell parliament to make a law. Health is a state subject. Bisaria pointed out that during the Covid pandemic, the Court took up a suo moto case to organize the supply of oxygen throughout the country. Incidentally, CJI Chandrachud had led this bench.

The bench remarked: “It was an unprecedented high oxygen demand situation. We are in a completely different situation today.

After learning that the matter was under consideration by the government, the bench agreed to review the guidelines before disposing of the petition.

Diabetes drug Ozempic in short supply as many mistakenly take it for weight loss Tue, 08 Nov 2022 11:08:17 +0000

Semaglutide, a prescription drug, sold primarily under the brand name Ozempic, is prescribed to help people with diabetes control their blood sugar levels and manage their weight over the long term.

In recent weeks, however, this drug has become a controversial topic as it has gone viral on social media as a weight loss solution – even for those without diabetes.

The clamor for Ozempic, which is sold as a liquid solution given by injection under the skin, has caused drug shortages. This has created serious problems for those who actually need their prescribed medication to ensure that their body can release insulin to control diabetes.

Jonathan Fialkow, MD, head of population health for Baptist Health and chief of cardiology at the Miami Cardiac & Vascular Institute.

“We constantly get calls from patients who can’t find it,” said Jonathan Fialkow, MD, Chief Population Health Officer for Baptist Health and Chief Cardiology Officer at Miami Heart and Vascular Institute. “Pharmacies are overwhelmed, and we’re jumping through hoops so they can keep taking the drugs.”

No one should take this medicine unless prescribed by a doctor who can supervise their treatment. Research has shown that those who are prescribed the drug and stop using it may regain weight, especially if they haven’t made any lifestyle changes.

The United States Food and Drug Administration (FDA) approved Ozempic in 2017 for use in people with type 2 diabetes. Ozempic signals the pancreas to create more insulin, which helps control blood sugar and reduces also glucagon, a hormone that raises blood sugar. It may cause weight loss, but Ozempic has not been approved for this purpose.

Serious side effects of Ozempic can include: diabetic retinopathy (damaged blood vessels in the eye); gallstones; kidney problems, including kidney failure; swelling of the pancreas; increased risk of thyroid cancer; allergic reaction and hypoglycaemia (low blood sugar). Milder side effects with Ozempic include nausea, diarrhea, abdominal pain, and vomiting. Low blood sugar can cause blurred vision, difficulty concentrating, confused thinking, slurred speech, numbness, and drowsiness.

“If you lose weight quickly and don’t start watching, you could pass out and break your hip or your head,” Dr. Fialkow said. “These drugs should be monitored by your doctor.”

The more serious risks may not even be well known because the effects of semaglutide (Ozempic) have not been studied well enough in a larger population.

“Are these people taking any other medications or do they have other conditions that may not be safe with Ozempic that have not been studied?” said Dr. Fialkow. “We don’t know enough about interactions with other drugs, which have their own established side effects that we know people will experience.”

Semaglutide belongs to a class of drugs known as glucagon-like peptide 1 (GLP-1) and is part of an established therapy for the management of type 2 diabetes. GLP-1 therapy is recommended at the beginning treatment of type 2 diabetes, also resulting in some weight reduction and favorable management of heart disease. In recent studies, GLP-1 therapies have been shown to be effective in reducing obesity, which is a primary risk factor for diabetes, in people with other underlying health conditions, including diabetes or prediabetes. , a condition that can lead to a diagnosis of type 2 diabetes.

In a recent study, another class of drugs – the glucose-dependent insulinotropic polypeptide (GIP) – was combined with GLP-1 to form another drug that is not yet widely available for weight loss. The new drug helps people lose weight by increasing incretin, which is the hormone that controls hunger.

Key words: ,

Iran donates batch of essential drugs and medical supplies to Sri Lanka Sat, 05 Nov 2022 16:11:00 +0000 *
Iran donates batch of essential drugs and medical supplies to Sri Lanka

Saturday, November 5, 2022, 9:41 p.m. SL time, ColomboPage News Desk, Sri Lanka.

November 5, Colombo: The Iranian government, in collaboration with the Iranian Red Crescent, donated a batch of essential drugs and other medical supplies worth more than Rs. 108 million to Sri Lanka.

The donation, consisting of 119 essential medical items, was handed over to Sri Lanka’s Ambassador to Iran GMV Wishwanath Aponsu by the Iranian government in the presence of senior officials from the Ministry of Foreign Affairs and the Iranian Red Crescent during a a ceremony held at the Red Crescent Office in Tehran on November 03, 2022.

In accepting the consignment, the Sri Lankan envoy expressed deep gratitude on behalf of the government and people of Sri Lanka to the Islamic Republic of Iran for their generous and timely contribution. Furthermore, the Sri Lankan Ambassador stressed Iran’s continued support to Sri Lanka in difficult times and stressed the importance of maintaining good relations and cooperation.

The donation of medical services is the result of a request made by Ambassador Aponsu during his meeting with Iran’s Deputy Minister of Health, Dr. Mohammed Hossein Niknam, Deputy Foreign Minister for Western Asia, on Dr Seyed Rasoul Mousavi, head of the Iranian Red Crescent. Dr. Pir Hossein Kolivand and senior officials from the Ministry of Foreign Affairs of Iran in June 2022 to brief on developments in Sri Lanka.

The Sri Lankan Embassy in Tehran made immediate arrangements with the support of Managing Director Alireza Bardaei of Pankeh Tea Pvt. ltd. to Iran to ship the medical consignment from Iran to Sri Lanka. The cargo is expected to arrive at Colombo Port by mid-November 2022.

Groups appeal Badger-Two Medicine oil and gas lease decision Wed, 02 Nov 2022 22:41:35 +0000

The Pikuni Traditionalists Association, a group representing the cultural and religious interests of the Blackfeet tribe, appealed a decision reinstate a federal oil and gas lease in Badger-Two Medicine.

Today’s appeal represents the latest development in a 40-year saga over federal energy permits in a 165,000-acre region of the Helena-Lewis and Clark National Forest, often described as the tribe’s spiritual homeland. of the Blackfeet.

The Badger-Two Medicine features in Blackfeet creation stories, provides tribal members with traditional foods and medicines, and serves as a corridor for wildlife traveling between Glacier National Park, the Bob Marshall Wilderness Complex, and the Indian Reservation. of the Blackfeets. It is designated a traditional cultural district and closed to motorized recreation.

Solanex, based in Louisiana, is seeking to build a temporary well pad and bridges in the Badger Two-Medicine for oil and gas drilling with a lease that has figured in administrative, court and legislative fights for decades.

The Clinton administration suspended the 6,200-acre lease in 1993, a move subsequent administrations have repeated under pressure from conservationists and tribal officials seeking to halt energy development in the area.

Congress passed a bill in 2006 that prohibited future leasing of the Badger-Two Medicine and incentivized remaining tenants to give up their leases. A decade later, the federal government canceled the Solanex leaseand Solanex challenged the revocation of the lease in court.

U.S. District Judge Richard Leon of Washington, D.C., sided with Solanex in his Sept. 9 ruling, reprimanding the Department of the Interior for subjecting the company to “an endless series of administrative reviews “. [that] banned all activity for almost forty years.


Shared State: Who decides the future of Badger Two-Medicine?

For many Montana residents, Badger-Two medicine is synonymous with one of the most significant conservation successes of decades. This story is about Blackfeet tribal traditionalists, political leaders, and conservation groups who come together to defeat oil and gas claims in an undeveloped wilderness of Montana. Now the coalition is faced with thorny questions: what does long-term protection and management of the badger look like, and who decides?

Leon rejected the federal government’s claim that drilling and building roads in the area would compromise the ecological and cultural value of the area by her decision canceling the termination of the lease. Leon claimed the lease was properly issued and the federal government functionally “waived” any right to cancel it.

The responders-defendants planned their intention to appeal Leon’s decision following the ruling, with Blackfeet Historic Preservation Officer John Murray telling Montana Public Radio “the fight is far from over. finished” in a September 13 article on the legal battle over the last remaining lease in Badger-Two medicine. They delivered on that commitment with the November 2 filing.

“The Blackfoot Confederacy, the Rocky Mountain Tribal Leaders Council, which represents the tribes of Montana, Idaho and Wyoming, and the National Congress of American Indians all stand with the Blackfoot Nation “said Tyson Running Wolf, member of the Pikuni Traditionalist Association and state representative. , D-Browning, said in a Nov. 2 emailed statement about the call. “We will never cede sacred ground to those who would defile it. And it’s not just about Indian Country, for decades now both Republican and Democratic administrations have backed a no-lease badger because the place matters to everyone in Montana.

The Blackfeet-Headwaters Alliance, Glacier Two-Medicine Alliance, National Parks Conservation Association, Wilderness Society and Wild Montana (formerly Montana Wilderness Association) have joined the call.

“Drilling in prime grizzly bear and elk habitat and a traditional cultural district makes no moral, environmental or economic sense and never will. Just as we have helped other tenants find retirement solutions that preserve the land and their businesses, we remain committed to exploring reasonable settlement options with Solanex,” said Peter Metcalf, Executive Director of Glacier-Two Medicine Alliance. , in the press release.

The statement goes on to say that parties opposed to the Badger-Two Medicine lease have made “several attempts” to settle the matter with Solanex, offering a range of alternatives including cash buyouts, tax credits, land swaps or access to tribal oil and gas fields.

David McDonald, an attorney with the Mountain States Legal Foundation, the law firm representing Solanex in the lawsuit, said his clients were waiting for the call but remained “excited and energized” by Leon’s decision.

“We’re ready to do whatever it takes to make this lease finally productive,” McDonald said.

In 2020, the United States Senator Jon Tester introduced the Badger-Two Medicine Protection Act, which sought, among other things, to make the current ban on road construction permanent and to prevent the construction of any additional buildings, pipelines or water installations in the area. He stalled in committee.

latest stories

Montana youth mental health needs are on the rise

According to a report from public high schools across the state, 41% of students said they felt so sad or hopeless for two or more weeks in a row during the 2020-2021 school year that they stopped their usual activities – a jump of 16% from 1999, when the study was first conducted.

U of I scientist becomes first inductee into Idaho National Academy of Medicine Sun, 30 Oct 2022 17:01:28 +0000

MOSCOW, Idaho (KIFI) – A University of Idaho researcher, internationally recognized for her work in maternal and child nutrition, has become the university’s first inductee into the famed National Academy of Medicine.

Michelle (Shelley) McGuire, director of the Margaret Ritchie School of Family and Consumer Sciences and professor in the College of Agricultural and Life Sciences, was nominated by colleagues at Yale University and the University of Illinois, who praised his long-term research on human milk.

McGuire is the first faculty member inducted into the academy while employed at an Idaho institution, according to organization records.

For several years, McGuire and her colleagues collected breast milk samples from nine countries to analyze their complex composition. She found that the composition of breast milk varies greatly depending on where the mother lives and thinks these differences likely encourage babies to thrive in their specific environment. At the start of the COVID-19 pandemic, the results of research from McGuire’s team – co-led by Mark McGuire and Janet Williams of the U of I and Courtney Meehan of Washington State University – provided vital advice for mothers who were worried about the potential for the coronavirus to spread via breastfeeding. . McGuire’s team found that breast milk provides infants with antibodies.

As a new member of the academy, McGuire will help inform national health policy and offer advice on human health research priorities. She will also help select future members of the academy and will be given priority to serve on expert panels commissioned by the academy to write reports on pressing scientific issues.

“In the United States, that’s about the best recognition a scientist can get,” McGuire said. “I hope this is the start of a growing number of national academy members at the University of Idaho.”

The National Academy of Medicine is a private, nonprofit organization with more than 2,400 fellows from around the world elected by their peers. It is one of three academies that make up the National Academies of Science, Engineering, and Medicine.

“Her time at the academy is a demonstration of what an incredible scientist she is and the incredible scientists we have at the university and at Idaho State,” said Christopher Nomura, vice president of the U of I for research and economic development. “Reputationally, it demonstrates that we have one of the best biomedical faculties on the planet here at the University of Idaho. His work literally has global impacts.

McGuire’s induction will help attract top faculty, postdoctoral researchers and graduate students to the U of I, Nomura said.

The National Academy of Medicine officially announced the 100 members of the class of 2022 at its annual meeting on Monday. The National Academies will hold an induction ceremony honoring the 2022 inductees in the fall of 2023. McGuire’s membership began immediately.

]]> Skyfarer and Medical Logistics UK collaborate to deliver medical supplies Fri, 28 Oct 2022 06:33:40 +0000

Skyfarer Ltd and partner Medical Logistics UK have announced a joint beyond visual line of sight medical drone delivery trial which will begin this week in a CAA approved area known as ‘The Medical Logistics UK Corridor’. .

Due to the increasing demands of the healthcare system, hospitals need essential and urgent medical supplies.

Skyfarer believes that these requests need to be handled efficiently due to the significant congestion on our roads and heavy infrastructure.

Georgia Hanrahan, Project Manager at Skyfarer, said: “There are no potholes in the sky, nor is there so much congestion, and without the need for heavy infrastructure to land, Unmanned Aerial Vehicles (UAVs) can add to the logistics transfer fleet and provide a faster, more environmentally friendly and less expensive solution.”

Connecting hospitals
The Medical Logistics UK Corridor will connect 32 kilometers of airspace between University Hospital Coventry and Warwickshire Trust hospitals in Coventry and Rugby for a three-month period from October to December 2022, enabling a record number of medical drones routine and ad hoc. the deliveries.

Skyfarer is a Coventry-based start-up founded in 2017 by Coventry University aerospace and engineering graduate Elliot Parnham with the aim of using drones for the good of society, with the first of their initiatives being Medical Drone Delivery.

Alex Landowski (Medical Logistics UK), Lucy Gilbert (UHCW) and Elliot Parnham (Skyfarer)

Parnham said: “I started Skyfarer in 2017 and it was all about this message of trying to bring about societal change and it’s through this new high value technology of UAVs, or drones, being used in emergency cases. ‘use positives like medical delivery.’

An innovative partnership
This trial, the first of its kind, is sponsored and made possible by London-based Medical Couriers, Medical Logistics UK.

Commenting on the new partnership, Alex Landowski, Managing Director of Medical Logistics, said: “I welcome our new partnership as an opportunity to revolutionize the UK medical supply chain. Using our emissions-free solution, this first land-based trial in the UK will achieve a record – a record number of routine and on-time medical deliveries.”

Based in London, Medical Logistics is a leading provider of urgent medical deliveries and personalized on-demand medical tests. Offering nationwide coverage, a competitive pricing structure and the highest standards in the market (CQC registered and UKAS accredited), Medical Logistics plans to take medical deliveries to the next level.

With a keen interest in technology, zero-emissions solutions and zero-emissions goals, drones were a clear need to add to the 90% electric medical vehicle fleet (100% by the end of 2023).

Medical Logistics’ goal is to serve its customers and the public by providing the highest standards with the introduction of real innovation and sustainability not seen in medical transportation and private healthcare.

This trial also kicks off the first leg of the Future Flight Phase 3 project corridor called “Skyway”, led by UTM partners and industry leaders Altitude Angel.

Skyway is a drone highway connecting 265km of the UK through the sky, allowing operators like Skyfarer to fly safely and regularly on BVLOS. Skyfarer is proud to be the lead operator on this project as the Medical Logistics UK Corridor is the first stop on the drone highway and creates a massive first step in completing the two-year project.

This trial is the first of its kind as it takes place on land, between two NHS Trust hospitals, in a hub-centric network running 24 hours a day, meaning all operations are controlled from a central location. and performed beyond visual line of sight.

Flights will be operated in all weather conditions throughout the rest of the year as well as at different times of the day so that the flight operations team can work with the Trust to determine how this technology can be permanently integrated into the future. The consortia want to ensure that it is accessible to every department whenever needed.

A series of routine and ad hoc emergency flights will also be carried out to determine the reliability of the Skyfarer service and future proof the NHS integration.

]]> In Newton, a road race raises funds for medical supplies to help those suffering in Ukraine Tue, 25 Oct 2022 22:53:30 +0000

The “tactical backpacks” cost between $1,000 and $1,200, and the cost includes high-tech medical supplies that are packed into the bag for professionals to treat injured people in Ukraine, Kosheleva said.

One bag can save the lives of 10 to 12 people, Migacheva said. They include surgical tools to operate on everything from wounds to collapsed lungs. She said she was delighted when Exxcel reached out to organize the event.

“We are impressed with the gracious support and the volunteers who show up to run,” said Migacheva. “It means a lot.”

Tatiana Kamarskaya, owner and co-founder of Exxcel Gym on Wells Avenue is from Kyiv, Ukraine, and said when the war started to escalate she wanted to help in any way she could.

“I wanted this race to show that someone is behind Ukraine,” said Kamarskaya. “We don’t forget them.”

Kamarskaya, who lives in Westwood, said her family, friends and former acrobatics students still live in Ukraine.

“I wanted to be part of something bigger than me,” Kamarskaya said of her work with Sunflower of Peace.

Kamarskaya said she was already planning a fall race to condition the athletes, but “it all started to get very real” when bombs hit about two blocks from her parents’ home in Ukraine.

“If we’re already running, it might as well be for something,” said Kamarskaya, who said she started doing a lot of research on the nonprofit to make sure the money would go. to people suffering from the Russian invasion.

During the race, participants were dressed in Ukrainian colors and wore white in anticipation of supporters throwing blue and yellow chalk at them from the touchline.

Known as the “Color Race”, the race included three loops along Wells Avenue. Kamarskaya said the event was open to the public, but many attendees were gym members and staff as well as parents.

Eliana Soiffer, a 15-year-old from Brookline who has been an Exxcel member for 11 years, said it was important to show up in times of pain.

“It’s a huge crisis,” Soiffer said. “Often events fade into the media, but that doesn’t mean they don’t happen.”

Before the race, Soiffer and her teammates performed a dance choreographed by Kamarskaya to the Ukrainian song “Stephanie” by the popular folk rap group Kalush Orchestra.

Sarah Linder, who lives in Allston and is a trainer at Exxcel in Newton, said she was delighted to see her athletes racing.

“Having fun outside of the gym and seeing my students in a different atmosphere is really nice,” Linder said.

Confetti, color and cheer kicked off the runners around 2:30 p.m. in two separate runs.

Anatoly Prekrasnyy of Cambridge and 2021 Boston Marathon finisher, won the race in 15 minutes and 10 seconds. Prekrasnyy said he used to volunteer for Peace Sunflower.

“It’s an event I couldn’t miss,” Prekrasnyy said. “It’s not only a great cause, but [it’s?] important to be here to support Ukraine.

Kherson, Ukraine, a resident describes a ghost town of exhausted people, with severe shortages of medicine Sat, 22 Oct 2022 15:02:00 +0000


A resident of Kherson described the situation in the city ​​occupied by Russia also tense, with people “emotionally exhausted”, the streets empty from the middle of the afternoon, and Russian soldiers often seen in civilian clothes.

The woman was reached by CNN through a third party and was speaking shortly before the Russian-appointed administration in the city ordered civilians to leave.

The administration said on Saturday that “due to the tense situation at the front, the increased danger of heavy bombardment of the city and the threat of terrorist attacks, all civilians should immediately leave the city and cross to the east bank. Dnipro!”

Previously, authorities had advised people to leave; Saturday’s announcement seems to go beyond that.

Speaking on Friday, Kherson City Civilian Woman said: “Unfortunately, many residents of Kherson had to consider leaving the city. Everyone had their own reasons, worries and fears. But I’m 100% sure no one wanted to go.

CNN is not identifying the woman for security reasons.

She said that Kherson had become a ghost town. Tens of thousands of its residents have left since the Russian occupation began in March.

“In the evening you can see a large number of high-rise buildings in which a maximum of two or three windows are illuminated. During the day, you can meet people mainly near the market. But at 3-4 p.m., the streets are empty and there is no one there at all.

On Saturday, a Ukrainian official, Yuriy Sobolevskyi, claimed on Telegram that the “wretched scum who terrorize Kherson” had ordered the closure of all elevators in the city.

The woman said she had no plans to leave. “To be honest, this question makes me furious… This is my land, Kherson is my home. We participated in rallies against the occupiers from the first days of the war, we fought as best we could. This struggle is still ongoing.

The woman said that in the past few days she had not heard of anyone being forced to leave. Some people were still trying to reach Vasylivka in the neighboring region of Zaporizhia, the only open crossing point between Russian and Ukrainian-held territories.

It is not clear whether this situation will now change after the latest instructions from the Russian-appointed authority.

The woman said the atmosphere in the town was tense. “People are emotionally drained, some just don’t leave their homes to avoid contact with the army. It is impossible to relax here. In the evening when I hear a car driving near the house, I start to get upset, because a car at a late hour is not a good sign.

She insisted that most of those who remained understood that the Ukrainian army “will never harm the population and there will be no shelling of civilians”.

The woman said that although utilities continued to operate, people were worried about adequate food and heating during the winter. “Everyone is afraid of the coming winter.”

She said there was enough basic food available. “Kherson has generally turned into a spontaneous market, people sell what they can. Someone bakes homemade bread, someone bakes cakes, someone sells their stuff just in the middle of the street by putting on a sheet.

But since the Russians had taken people’s boats, she didn’t know how food deliveries from the east bank would be maintained.

The woman said medical supplies and infant formula were in short supply and very expensive. “Everything imported now is medicine from the Russian Federation. Drugs are sold simply on the street from the car or by some people in private.

There were always long queues at pharmacies and things like antibiotics were in short supply.

She did not know whether the number of Russian soldiers in the city of Kherson had increased or decreased, but had noticed a growing contingent of Chechen fighters in the city.

“I can’t say that there are less Russian soldiers, they just took off their military uniforms and put on civilian clothes. Some walk in the street in civilian clothes but with a machine gun.

She said she welcomed the sound of shelling.

“The people of Kherson are frightened by the silence. I remember, it was quiet for a few days in the summer, and it seemed to everyone that Ukraine had forgotten about us.

“You can constantly hear how the Ukrainian armed forces shell the positions of the occupiers. You can’t even imagine how happy the locals are because of this,” she said.

“Periodically, automatic weapons are heard in different parts of the city, but it’s unclear who is having a firefight.”

Ukrainian forces are still some distance from the city of Kherson but have made inroads in other parts of the region. Russian forces appear to be entrenched and defending their positions, while launching missile attacks against the Ukrainian advance. Russian-appointed local officials insist Moscow’s forces intend to defend the area, while Ukrainian officials say up to 45 Russian battalion battlegroups could now be on the west bank of the Dnipro.

But Ukrainian officials say that in some parts of Kherson, such as Beryslav, the occupation authorities have ceased their activities in recent days. “Collaborators who cooperated with the Russian occupiers continue to leave the city with their families and property,” the Ukrainian army said on Friday.

In recent days, Ukrainians have hit a newly erected pontoon under the Antonivskyi Bridge, which is near the city of Kherson. Local authorities said four people were killed.